Hsiao Dee Lieu's Insider Trades & SAST Disclosures
Hsiao Dee Lieu's most recent trade in Ngm Biopharmaceuticals Inc was a trade of 190,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 5, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Hsiao Dee Lieu.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 190,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 159,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 150,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 150,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 39,750 | 0 | - | - | Restricted Stock Unit | |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | Chief Medical Officer | 05 Apr 2024 | 19,349 | 0 (0%) | 0% | - | Common Stock | ||
| Ngm Biopharmaceuticals Inc | Dee Hsiao Lieu | EVP, CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.34 per share. | 16 Jan 2024 | 5,430 | 54,254 (0%) | 0% | 1.3 | 7,276 | Common Stock |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 159,000 | 159,000 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 53,000 | 55,605 (0%) | 0% | 0 | Common Stock | |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 05 Oct 2021 | 2,000 | 0 (0%) | 0% | 22 | 44,000 | Common Stock |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.06 per share. | 05 Oct 2021 | 2,000 | 2,000 (0%) | 0% | 12.1 | 24,120 | Common Stock |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2021 | 2,000 | 190,000 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2021 | 8,000 | 192,000 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.50 per share. | 11 Aug 2021 | 8,000 | 0 (0%) | 0% | 23.5 | 188,000 | Common Stock |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.06 per share. | 11 Aug 2021 | 8,000 | 8,000 (0%) | 0% | 12.1 | 96,480 | Common Stock |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 11 Aug 2021 | 2,258 | 0 (0%) | 0% | 23 | 51,934 | Common Stock |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Hsiao Dee Lieu | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 15 May 2020 | 1,562 | 182 (0%) | 0% | 22 | 34,364 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges